Enter search term

Does your SARS-CoV-2 antibody test system give you the full picture?

Nov 3, 2021

ZEUS ELISA SARS-CoV-2 assays detect immune responses that other antibody tests may miss

The ZEUS ELISA SARS-CoV-2 Antibody Test Systems' unique dual antigen design detects antibodies to both the Nucleocapsid protein and the Spike protein S1 receptor binding domain (RBD).  This unique design has been optimized for superior sensitivity and specificity in the detection of antibodies in both serum and plasma.  These tests allow for the detection of antibodies produced by a natural SARS-CoV-2 infection and/or from vaccination. Most available SARS-CoV-2 antibody tests target one but not both proteins.  ZEUS ELISA SARS-CoV-2 assays detect immune response that other antibody tests may miss. Your patients deserve the ZEUS dual antigen difference.

Both the ZEUS ELISA SARS-CoV-2 IgG and Total (IgG, IgM, IgA) Antibody Test Systems have been authorized by the FDA for Emergency Use (EUA) for use manually or with any of the Dynex suite of automated ELISA systems which includes the DSX®, DS2® and Agility®.  The ZEUS ELISA SARS-CoV-2 Test Systems utilize SmartKit® Gold Packaging, providing the ultimate level of convenience by allowing your your laboratory to take full time-saving advantages of the Dynex Agility Automated ELISA System.

Dynex Agility and ZEUS ELISA SARS-CoV-2 Test Systems take your testing to the next level!

  • Frees up significant labor time and allows for multitasking
  • Eliminates nearly all manual liquid-transfer steps


Test with Confidence.
Test with ZEUS.

Improve your SARS-CoV-2 antibody testing offering with ZEUS Scientific. Put the power of our dual antigen design to work in your lab!

Contact our sales team today to get pricing and learn more at zeuscovid.com.



The ZEUS Scientific Family


Back Share